Navigation Links
New Guidelines For Assessing Lymphoma Treatment

An international team of cancer specialists and imaging experts has developed standardized guidelines for assessing lymphoma response to treatment//. The guidelines will provide clinicians worldwide with uniform criteria to compare and interpret clinical trials of lymphoma treatments and should facilitate the development of new therapies.

The new guidelines developed by the International Harmonization Project (IHP) build on criteria for treatment response assessment of non-Hodgkin's lymphoma published in 1999 by an international working group (IWG) of clinicians, radiologists and pathologists. Although the IWG criteria have been widely adopted by clinicians and regulatory agencies and used to approve several treatments, recent advances, including increased use of positron emission tomography (PET) scans and immunohistochemistry in lymphoma response assessment, prompted the IHP to substantially revise the criteria.

The IHP recommendations aim to standardize the parameters used in clinical trials for lymphoma and incorporate the new technologies. In addition, the revised guidelines cover all lymphomas. The recommendations appear in the Jan. 22 online issue of the Journal of Clinical Oncology. Bruce Cheson, M.D., professor of medicine at the Lombardi Comprehensive Cancer Center at Georgetown University Hospital, is senior author of the paper and led the IHP effort.

Integration of PET represents a major change in the guidelines. Malik Juweid, M.D., associate professor of radiology at the UI Roy J. and Lucille A. Carver College of Medicine and a member of the UI Holden Comprehensive Cancer Center, was co-chair of the IHP committee that developed the recommendations for performing and interpreting PET scans in response assessment of lymphoma. The imaging committee, which included world-renowned PET imaging experts from the United States, Europe and Australia, was co-chaired by Sigrid Stroobants from University Hospital Gasthuisberg in Le
'"/>




Page: 1 2 3

Related medicine news :

1. New CPR Guidelines issued by Heart Association
2. New Guidelines Found To Benefit Cardiovascular Treatment
3. Healthy Feeding Guidelines for Children Ages 0 to 24 Months Issued
4. Fragile X-Associated Tremor /Ataxia Syndrome Need Guidelines For Diagnostic Tests
5. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
6. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
7. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
8. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
9. Guidelines for treatment of juvenile idiopathic arthritis formulated
10. Guidelines For Better Management Of Obsessive-Compulsive Disorder
11. Poultry Workers To Adopt Anti-Flu Guidelines
Post Your Comments:
(Date:7/9/2008)..., Barcelona, Spain: New figures on assisted repro... has been an explosion in the use of ICSI (intracy...he 24th annual meeting of the European Society of ...lona heard today (Wednesday). Researchers believe ... too often. , In 2005 the most recent year for ...
(Date:7/8/2008)..., Alexandria, Va.A study conducted in Sweden foun...untry whose wives died from cancer four or five ye...hat their spouse,s cancer was incurable, or they h...life. Eighty-six percent of widowers believed next...ancer is incurable, including 71 percent of the me...
(Date:7/8/2008)... CHICAGO, July 8 /PRNewswire/ -- Last month th...e Improvements for Patient and Providers Act",(H.R...re payments to,physicians and other providers went...ent relationship in great jeopardy., , To view t...ewswire.com/mnr/osteopathic/33934/ , The American...
(Date:7/8/2008)... Heart Failure Study Validates Use of Pharos In...ing Platform to Reduce Healthcare Utilization and ...IELD, Ill., July 8 /PRNewswire/ -- Pharos Innovati...t generation clinical and financial,performance im...platform,announced today the results from the Iow...
Breaking Medicine News(10 mins):Health News:Researcher say that ICSI may be over-used in some countries 2Health News:Researcher say that ICSI may be over-used in some countries 3Health News:Study finds that significant proportion of men told wife's cancer was incurable late or not at all 2Health News:Audio: Medicare Cuts Threaten Access to Health Care for Seniors 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3
...ise that constant stress can make people sick, and...study focused on 119 men and women who were taking...caregivers was compared with that of 106 people of...e stress of constant care giving. Blood tests show...
...investigators more than 10 million children worldw...nd many of them preventable with existing medical ...these nations has dropped over the past half centu...f of the deaths in children under 5 take place in ...
...le who are bitten by animals poses little problem ... another human? That’s the question researchers se...onth’s Otolaryngology -- Head and Neck Surgery. Th...ords in Galveston, Texas, identified several key a...
... that early detection is important for preventing ...be as easy as mirrors with no tricks, just light.J...e’s lucky doctors were able to treat him despite a...ound a primary, which is what you call the skin ca...
Other Medicine News:
(Date:7/8/2008)...RNewswire/ -- Avir Green Hills Biotechnology,start...cine deltaFLU,against pandemic influenza. This nov...n the deletion of the NS1 gene has shown superior,...e biotech company sets,yet another milestone in th...m of Phase I Study, The randomized, double-blind ...
(Date:7/8/2008).../- After meeting on July 1st and,2nd ...betes drugs should,undergo trials to rule out card...f US endocrinologists agree with this recommendati...diovascular and metabolic primary market,research ...obal Life,Sciences Industry., On July 3rd AlphaDe...
(Date:7/8/2008)...eets primary endpoints in ENGAGE Trial, KENILWORT...-Plough,Corp., (NYSE: SGP ) announced today that ...follicle stimulant (SFS) met its primary endpoints...presented during a,Schering-Plough-sponsored sympo...ciety of Human Reproduction and Embryology (ESHRE)...
(Date:7/7/2008)...proves Cognition and is Well Tolerated in ...ndings Warrant Further Development in Huntington,s...Today at 5:00 p.m. EDT -, SAN FRANCISCO, July 7 /... MDVN ) today announced top-line results of a Pha...imebon(TM) significantly improved cognitive,functi...
Breaking Medicine Technology:Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU 2Start of Phase I Study for Intranasal Pandemic Influenza Vaccine deltaFLU 3AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panel's Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications. 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 2Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 2Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 3Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 4Medivation Announces Positive Top-Line Results From Phase 2 Dimebon Study in Huntington's Disease 5UCR plant cell biologist to study how plant stem cells maintain and change their identity 297 1UCR plant cell biologist to study how plant stem cells maintain and change their identity 297 2Prime Therapeutics Receives TIPPS Certification 729 1Prime Therapeutics Receives TIPPS Certification 729 2Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences 727 1Standard Management Announces OTCBB Listing 725 1Standard Management Announces OTCBB Listing 725 2
...monstrate Significant Survival Benefit in,Liver Ca...ll/ -- Bayer,HealthCare Pharmaceuticals Inc. and O...avar(R) (sorafenib) tablets significantly,extended...carcinoma,(HCC), or primary liver cancer versus th...). Results were presented at the 43rd,annual meeti...
...NESS WIRE)--Jun 4, 2007 - GenVec, Inc.,(Nasdaq: GN...y and,efficacy data from the clinical development ...nted in a poster session on,gastrointestinal cance...linical Oncology in Chicago, IL by Dr. Mitchell Po...sion of the posters then,concluded the Saturday mo...
Other Medicine Technology:Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 2Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 3Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 4Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 5Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 6Nexavar Significantly Extends Overall Survival by 44% in Liver,Cancer Patients 7GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 2GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 3GenVec Announces Update of Safety and Efficacy Data from Pivotal,Phase II/III PACT Study of TNFerade at ASCO 4
...igation system for ENT, cranial and spine procedur...y, critical zones visible during tracking. Image f...n freezes image, snapshot can be taken of frozen i...the microscope, low profile receiver attachment. A...
The spinal system neon is a modular system for posterior stabilization. Its application range extends from occipitocervical via cervical to cervicothoracic applications. In the case of children, it c
Bacon Cranial Rongeur
Cushing Pituitary Rongeur
Medicine Products: